Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study;Gesundheitsbezogene Lebensqualität bei Patienten mit Vorhofflimmern in der kardiologischen Versorgung: MOVE-Studie

Deutsche Medizinische Wochenschrift

Volumn 135, Issue SUPPL. 2, 2010, Pages

  Kirch, W ^a   Pittrow, D ^a   Bosch, R F ^b   Kohlhauen, A ^c   Willich, S N ^d   Rosin, L ^c   Bonnemeier, H ^e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Kardiologische Praxis   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Atrial fibrillation; Burden of disease; Cross sectional study; Quality of life

Indexed keywords

ARTICLE; CARDIOLOGIST; CARDIOVERSION; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; MEDICAL DOCUMENTATION; PREVALENCE; QUALITY OF LIFE;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELECTRIC COUNTERSHOCK; EMERGENCY SERVICE, HOSPITAL; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE; UTILIZATION REVIEW;

EID: 77949381155     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1249205     Document Type: Article

References (34)

1. Bonnemeier H, Kirch W, Kohlhauβen A, Pittrow D, Willich S, Bosch R. Vorhofflimmern in der kardiologischen Versorgung in Deutschland: MOVE Studie [Abstract 490]. Vortrag bei der 76. Jahrestagung der Deutschen Gesellschaft für Kardiologie,. Mannheim 8.-10.4.2010
2. Bosch R, Kirch W, Kohlhauβen A, Pittrow D, Willich S, Bonnemeier H. Krankheitsbelastung und Lebensqualität bei Patienten mit Vorhofflimmern: EQ-5D und AFSS-Skalen in der MOVE-Studie [Abstract 492]. Posterpräsentation bei der 76. Jahrestagung der Deutschen Gesellschaft für Kardiologie,. Mannheim 8.-10.4.2010
3. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003 41 1690-1696
4. Committe for Medicinal Products for Human Use (CHMP). Note for Guidance on Antiarrhythmics (daft). Addendum on atrial fibrillation. http://www.ema. europa.eu/pdfs/human/ewp/35243808en.pdf Zugriff am 22.2.2010
5. Dorian P, Guerra P G., Kerr C R. et al. Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale. Circ Arrhythm Electrophysiol 2009 2 218-224
6. Dorian P, Jung W, Newman D, Paquette M et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000 36 1303-1309
7. Dorian P, Mangat I. Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. Card Electrophysiol Rev 2003 7 276-279
8. Dorian P, Paquette M, Newman D, Green M, Connolly S J., Talajic M, Roy D. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002 143 984-990
9. Fuster V, Ryden L E., Cannom D S. et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006 48 e149-246
10. Gemeinsamer Bundesausschuss. Verfahrensordnung.BAnz. Nr. 242 (S. 16 998) vom 24.12.2005. http://www.g-ba.de/downloads/39-261-277/2005-09-20-VO-BANZ.pdf Zugriff am 14.2.2010
11. Go A S., Hylek E M., Phillips K A., Chang Y, Henault L E., Selby J V., Singer D E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001 285 2370-2375
12. Greiner W, Claes C, Busschbach J J., von der Schulenburg J M. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005 6 124-130
13. Gronefeld G C., Lilienthal J, Kuck K H., Hohnloser S H. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. Eur Heart J 2003 24 1430-1436
14. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006 4 79
15. Hagens V E., Ranchor A V., Van Sonderen E et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004 43 241-247
16. Hohnloser S H., Crijns H JGM, van Eickels M, Gaudin C, Page R L., Torp-Pedersen C, Connolly S J., for the Athena Investigators. Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation. N Engl J Med 2009 360 668-678
17. Howes C J., Reid M C., Brandt C et al. Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation. J Cardiovasc Pharmacol Ther 2001 6 23-29
18. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Allgemeine Methoden 3.0 vom 27.5.2008. http://www.iqwig.de/ download/IQWiG-Methoden-Version-3-0.pdf Zugriff am 14.2.2010
19. Jenkins L S., Brodsky M, Schron E et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005 149 112-120
20. Kang Y, Bahler R. Health-related quality of life in patients newly diagnosed with atrial fibrillation. Eur J Cardiovasc Nurs 2004 3 71-76
21. Kim M H., Lin J, Hussein M, Kreilick C, Battleman D. Cost of atrial fibrillation in United States managed care organizations. Adv Ther 2009 26 847-857
22. Kirchhof P, Auricchio A, Bax J et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007
23. Kirchhof P, Auricchio A, Bax J et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007 9 1006-1023
24. Koller M, Neugebauer E A., Augustin M et al. Assessment of quality of life in health services research conceptual, methodological and structural prerequisites. Gesundheitswesen 2009 71 864-872
25. Lee W C., Lamas G A., Balu S, Spalding J, Wang Q, Pashos C L. Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. J Med Econ 2008 11 281-298
26. Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C, Dorian P. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol 2000 86 764-768
27. Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 1998 317 1191-1194
28. Singh B N., Connolly S J., Crijns H J. et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007 357 987-999
29. Singh S N., Tang X C., Singh B N., Dorian P et al. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 2006 48 721-730
30. Szende A, Leidy N K., Revicki D. Health-related quality of life and other patient-reported outcomes in the European centralized drug regulatory process: a review of guidance documents and performed authorizations of medicinal products 1995 to 2003. Value Health 2005 8 534-548
31. Thrall G, Lane D, Carroll D, Lip G Y. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006 119 448 e1-19
32. van den Berg M P., Hassink R J., Tuinenburg A E. et al. Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur Heart J 2001 22 247-253
33. Wyse D G., Waldo A L., DiMarco J P. et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 1825-1833
34. Dagres N, Nieuwlaat R, Vardas P E. et al. Gender-related differences in presentation, treatment and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007 49 572-577